Who we serve
From emerging biotech ventures to global pharmaceutical leaders—both brand and generic—Dr.Evidence empowers life sciences organizations to make smarter, faster decisions across the product lifecycle.
Established Biopharma
Master complexity across a global portfolio
When your organization is managing dozens of products across a wide range of global markets, landscape intelligence can't be fragmented. You need an Authoritative Source that scales with your business.
We help you
Harmonize
Harmonize global labeling strategies across therapeutic areas and geographies, identifying opportunities to streamline without compromising accuracy.
Streamline
Streamline approvals with the ability to automate manual processes and rapidly and accurately incorporate prior precedent.
De-risk
De-risk lifecycle management decisions with competitive intelligence that reveals how peers are navigating label expansions, safety updates, and indication changes.
Accelerate
Accelerate post-approval changes by instantly understanding regulatory precedent across markets.
Prepare
Prepare for negotiations with health authorities and respond to regulatory inquiries.
Your teams gain hours back each week, and can make decisions backed by comprehensive landscape intelligence, not guesswork.
“What took more than a couple of hours to complete now took less than 30 minutes.”
Director, Regulatory Affairs, Top-tier Pharmaceutical Company
“I defined a search, and within seconds, found an example that had not been identified by a colleague who searched for a couple days.”
Associate Director, Regulatory Affairs, Top-tier Pharmaceutical Company
Emerging Biopharma
Turn regulatory agility into competitive advantage
You're moving fast with lean teams. Each day counts, and every labeling or regulatory misstep could cost you valuable time. You need landscape intelligence that keeps pace with market demands and opportunities.
We help you
Optimize
Optimize your label from day one by understanding what regulators have accepted for similar molecules.
Accelerate
Compress timelines from first-in-human to approval with rapid insights into precedent-proven regulatory pathways in your therapeutic area.
Compete
Compete at peak performance with enterprise-grade labeling and regulatory intelligence at a fraction of the cost of building in-house capabilities.
Stop drowning in browser tabs and manual research. Get the insights that market-leading companies have — without their overhead.
“…crucial in comparison of competitor labeling”
Associate Director, Regulatory Labeling, Mid-market Pharmaceutical Company
“I defined a search, and within seconds, found an example that had not been identified by a colleague who searched for a couple days.”
Senior Safety Scientist, Mid-market Biotechnology Company
Generics & Biosimilars Manufacturers
Stay compliant and drive commercial success with automation and global landscape intelligence.
In generics, margin compression is relentless, and regulatory risk and complexity is rising. You need to stay on top of reference listed drug label changes, identify opportunities faster, and execute flawlessly to stay profitable.
We help you
Stay Ahead
Stay up to date on reference listed drug label updates with automated notifications when a label changes.
Submit Quickly
Accelerate regulatory submissions with instant access to reference listed drug labeling history and regulatory precedent.
Innovate
Identify white space opportunities by monitoring label changes, patent expirations, and competitive activity across your pipeline.
Maximize
Reduce time and labor spent on labeling comparisons from days to minutes with side-by-side comparison tables.
When you're managing hundreds of SKUs across multiple markets, efficiency is everything. Our platform turns regulatory complexity into a strategic advantage with automated intelligence.
“The process of automated label monitoring eliminates 40-60% of the effort compared to doing it manually. This allows us to be more strategic, support other teams, and expand into new geographies.”
Associate Director of Labeling, Top-tier generics company.
“With automation, safety updates are on time. It lets managers to more quickly manage safety updates and optimizes the pharmacovigilance team’s focus.
Associate Director of Labeling, Top-tier generics company.
One Platform.
Three Ways to Win.
No matter where you are in the life sciences ecosystem, landscape intelligence shouldn't be your bottleneck. Our platform adapts to your business model, your portfolio, and your pace.
Ready to see how we can de-risk and accelerate your labeling and regulatory strategy?
Frequently asked questions
© 2025 | Dr.Evidence